Atropos Health
Founded Year
2019Stage
Series B | AliveTotal Raised
$50.33MValuation
$0000Last Raised
$33M | 1 yr agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+51 points in the past 30 days
About Atropos Health
Atropos Health specializes in transforming healthcare data into actionable evidence for the healthcare and life sciences sectors. The company offers solutions that support clinical decisions, optimize health systems, and accelerate clinical research by leveraging a vast network of patient records and analytics tools. Atropos Health primarily serves the healthcare industry, including health systems and life science companies, by providing insights for formulary design, quality improvement programs, and clinical trial emulations. It was founded in 2019 and is based in New York, New York.
Loading...
Atropos Health's Product Videos
_thumbnail.png?w=3840)
_thumbnail.png?w=3840)
ESPs containing Atropos Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The real-world data providers market offers a variety of value propositions to the pharmaceutical industry, drug labs, and healthcare organizations. It provides access to diverse patient populations, longitudinal real-world data, and patient-powered or EHR-powered controls that can replicate real-world scenarios. This can help shorten drug development timelines, reduce patient recruitment burdens …
Atropos Health named as Challenger among 15 other companies, including IQVIA, Tempus, and Datavant.
Atropos Health's Products & Differentiators
ChatRWD™ (Chat Real World Data)
ChatRWD is a generative AI tool that delivers clinical answers more accurately than LLMs such as ChatGPT and Google Gemini. It leverages real-world data from the Atropos Evidence™ Network, which contains over 300 million anonymized patient records. The impact of ChatRWD extends beyond its technical capabilities; it represents a shift in how healthcare data is accessed and utilized. Built on Atropos Health technology, GENEVA OS™, ChatRWD is the first application to incorporate chat-to-database functionality, allowing users to generate high-quality evidence rapidly without compromising data security. GENEVA OS operates locally at the customer’s site, ensuring no patient-level clinical or claims data is exposed to LLMs.
Loading...
Research containing Atropos Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Atropos Health in 7 CB Insights research briefs, most recently on May 16, 2025.
May 16, 2025 report
Book of Scouting Reports: 2025’s AI 100
Apr 24, 2025 report
AI 100: The most promising artificial intelligence startups of 2025
Aug 21, 2024
The clinical trials tech market map
Jan 11, 2024
The generative AI in healthcare market map
Expert Collections containing Atropos Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Atropos Health is included in 5 Expert Collections, including Digital Health.
Digital Health
11,422 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
AI 100 (All Winners 2018-2025)
200 items
Digital Health 50
50 items
Artificial Intelligence
10,195 items
AI 100 (2025)
100 items
Atropos Health Patents
Atropos Health has filed 62 patents.
The 3 most popular patent topics include:
- medical equipment
- surgical procedures and techniques
- digestive system surgery
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/27/2021 | 3/25/2025 | Abdomen, Medical equipment, Surgical removal procedures, Digestive system surgery, Surgical procedures and techniques | Grant |
Application Date | 7/27/2021 |
|---|---|
Grant Date | 3/25/2025 |
Title | |
Related Topics | Abdomen, Medical equipment, Surgical removal procedures, Digestive system surgery, Surgical procedures and techniques |
Status | Grant |
Latest Atropos Health News
Aug 19, 2025
게티이미지 뱅크 [팜뉴스=우정민 기자] 노바티스(Novartis)가 인공지능(AI) 기반 현실 진료 데이터(RWE) 플랫폼 기업 아트포스 헬스(Atropos Health)와 손잡고 희귀질환 조기 진단 가속화에 나섰다. 양사는 AI 모델을 활용해 아직 진단받지 못한 환자를 조기에 식별하고, 증상 보고부터 진단·치료에 이르는 과정을 단축하는 것을 목표로 한다. 첫 단계는 발작성 야간 혈색소뇨증(PNH) 진단 개선에 집중된다. PNH는 면역 체계가 적혈구를 공격하는 희귀 혈액 질환으로, 전 세계 인구 백만 명당 10~20명에게 발생한다. 증상이 여러 장기에 걸쳐 나타나 진단까지 지연되는 경우가 많으며, 상당수 환자가 1년 이상, 길게는 5년 이상을 기다려야 한다. 이로 인해 30~40대에 이르러서야 진단을 받는 사례도 흔하다. 혈전이나 장기 손상 같은 합병증 위험도 커져 조기 식별의 필요성이 강조된다. 노바티스 미국 항암제 사업부 책임자 로드니 길레스피(Rodney Gillespie)는 “이번 프로젝트는 PNH에 대한 조기 진단과 시의적절한 치료에 집중한다는 회사의 방향성을 보여준다”고 밝혔다. 노바티스는 2023년 말 미국에서 PNH 최초의 경구 단일 요법으로 승인된 Fabhalta를 판매 중이다. 아트포스 헬스는 협력의 일환으로 환자 장기 진료 기록과 현장 진료 데이터(RWD)를 기반으로 훈련된 초기 AI 알고리즘을 구축했다. 이 도구는 의료 시스템에 바로 적용 가능하며, 환자가 증상을 보고한 뒤 진단과 치료에 이르는 과정을 단축하도록 설계됐다. 브리검 하이드(Brigham Hyde) 아트포스 헬스 CEO는 “고품질 현장 진료 데이터를 바탕으로 훈련된 AI 모델은 정밀의학의 새로운 단계”라며 “임상의의 추측을 줄이고 환자가 더 빨리 검사를 받아 더 나은 치료를 경험할 수 있도록 돕는다”고 강조했다. 향후 개발될 AI 모델들은 아트포스 헬스의 GENEVA OS와 아트포스 에비던스 네트워크(Atropos Evidence Network)의 현장 진료 데이터를 활용한다. 이 시스템은 병원 자체 클라우드 환경에서 환자 의료 기록을 검색 가능한 이력 타임라인으로 전환해, 민감한 정보를 외부로 이동시키지 않고도 수분 만에 증거를 생성할 수 있다. 네트워크는 3억 건 이상의 환자 데이터를 보유한 업계 최대 규모이다. 노바티스와 아트포스 헬스는 AI와 머신러닝을 활용해 진단 지연을 줄이고 환자 치료를 앞당기는 것이 정밀 건강의 진전을 이끄는 핵심이라고 강조한다. 이번 협력은 데이터 기반 의사결정이 현실화되는 시대에 의료 혁신 속도를 높여 환자 삶의 질을 개선하는 중요한 이정표가 될 것으로 전망된다. 키워드
Atropos Health Frequently Asked Questions (FAQ)
When was Atropos Health founded?
Atropos Health was founded in 2019.
Where is Atropos Health's headquarters?
Atropos Health's headquarters is located at 169 Madison Avenue, New York.
What is Atropos Health's latest funding round?
Atropos Health's latest funding round is Series B.
How much did Atropos Health raise?
Atropos Health raised a total of $50.33M.
Who are the investors of Atropos Health?
Investors of Atropos Health include Breyer Capital, Emerson Collective, Presidio Ventures, McKesson Ventures, Merck Global Health Innovation Fund and 10 more.
Who are Atropos Health's competitors?
Competitors of Atropos Health include Aetion and 8 more.
What products does Atropos Health offer?
Atropos Health's products include ChatRWD™ (Chat Real World Data).
Who are Atropos Health's customers?
Customers of Atropos Health include Stanford Medical Center, https://www.mayoclinic.org/ , Everycure and TD2.
Loading...
Compare Atropos Health to Competitors
Komodo Health specializes in healthcare analytics and operates within the healthcare technology sector. The company offers a platform that provides insights by analyzing a range of healthcare data, aiming to improve patient care and reduce disease burden. Komodo Health primarily serves life sciences companies, healthcare practitioners, payers, and patient advocacy groups with its suite of software applications designed to deliver value in healthcare through data-driven insights. It was founded in 2014 and is based in San Francisco, California.
Evidation is involved in measuring health in everyday life within the digital health sector. The company provides a platform for individuals to track health activities, participate in research, and manage their data privacy. Evidation serves the life sciences, government, and non-profit organizations. It was founded in 2012 and is based in San Mateo, California.
Datavant is a health data platform company that focuses on health data security, accessibility, and usability. The company provides a platform and network that allow for data exchange and interoperability within the healthcare ecosystem, allowing organizations to connect and use real-world data. Datavant serves health plans, healthcare providers, life sciences, government, non-profits, and data analytics sectors. It was founded in 2017 and is based in Phoenix, Arizona.
Culmination Bio focuses on the development of novel clinical insights, diagnostics, and therapeutics in the healthcare sector. It offers the development of therapeutic targets, diagnostic opportunities, and care process models. It was founded in 2022 and is based in Saint George, Utah.
Dandelion operates as a healthcare technology company that uses a precision medicine platform and clinical artificial intelligence (AI) marketplace. The company provides services that integrate patient data with AI tools to support clinical research, development, and commercialization. Dandelion serves the life sciences sector, offering solutions for early clinical research, clinical development, post-approval product differentiation, and indication expansion. It was founded in 2020 and is based in Syosset, New York.
Briya is a company that operates within the healthcare and life sciences sectors, providing a platform for retrieval and sharing of longitudinal data to support research and healthcare innovation. Briya serves healthcare organizations, life sciences companies, and academic researchers by providing tools to access real-world data for research and treatment. It was founded in 2020 and is based in New York, New York.
Loading...